Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb Income Taxes 2010-2025 | BMY

Bristol Myers Squibb annual/quarterly income taxes history and growth rate from 2010 to 2025. Income taxes can be defined as the total amount of income tax expense for the given period.
  • Bristol Myers Squibb income taxes for the quarter ending March 31, 2025 were $509M, a 29.85% increase year-over-year.
  • Bristol Myers Squibb income taxes for the twelve months ending March 31, 2025 were $671M, a 132.18% increase year-over-year.
  • Bristol Myers Squibb annual income taxes for 2024 were $0.554B, a 38.5% increase from 2023.
  • Bristol Myers Squibb annual income taxes for 2023 were $0.4B, a 70.76% decline from 2022.
  • Bristol Myers Squibb annual income taxes for 2022 were $1.368B, a 26.2% increase from 2021.
  
Bristol Myers Squibb Annual Income Taxes
(Millions of US $)
2024 $554
2023 $400
2022 $1,368
2021 $1,084
2020 $2,124
2019 $1,515
2018 $1,021
2017 $4,156
2016 $1,408
2015 $446
2014 $352
2013 $311
2012 $-161
2011 $1,721
2010 $1,558
2009 $1,182
Bristol Myers Squibb Quarterly Income Taxes
(Millions of US $)
2025-03-31 $509
2024-12-31 $99
2024-09-30 $461
2024-06-30 $-398
2024-03-31 $392
2023-12-31 $-88
2023-09-30 $203
2023-06-30 $-218
2023-03-31 $503
2022-12-31 $-166
2022-09-30 $601
2022-06-30 $529
2022-03-31 $404
2021-12-31 $-514
2021-09-30 $605
2021-06-30 $492
2021-03-31 $501
2020-12-31 $-424
2020-09-30 $379
2020-06-30 $1,707
2020-03-31 $462
2019-12-31 $931
2019-09-30 $-17
2019-06-30 $337
2019-03-31 $264
2018-12-31 $347
2018-09-30 $255
2018-06-30 $135
2018-03-31 $284
2017-12-31 $3,027
2017-09-30 $327
2017-06-30 $373
2017-03-31 $429
2016-12-31 $188
2016-09-30 $344
2016-06-30 $427
2016-03-31 $449
2015-12-31 $-222
2015-09-30 $257
2015-06-30 $162
2015-03-31 $249
2014-12-31 $-87
2014-09-30 $276
2014-06-30 $114
2014-03-31 $49
2013-12-31 $134
2013-09-30 $126
2013-06-30 $0
2013-03-31 $51
2012-12-31 $-411
2012-09-30 $-546
2012-06-30 $251
2012-03-31 $545
2011-12-31 $363
2011-09-30 $475
2011-06-30 $483
2011-03-31 $400
2010-12-31 $571
2010-09-30 $312
2010-06-30 $324
2010-03-31 $351
2009-12-31 $188
2009-09-30 $366
2009-06-30 $353
2009-03-31 $275
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $95.425B $48.300B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $220.067B 16.43
Amgen (AMGN) United States $150.262B 13.46
Gilead Sciences (GILD) United States $135.700B 14.09
Vertex Pharmaceuticals (VRTX) United States $114.532B 0.00
GSK (GSK) United Kingdom $81.374B 9.67
CSL (CSLLY) Australia $78.229B 0.00
Regeneron Pharmaceuticals (REGN) United States $65.131B 15.81
Alnylam Pharmaceuticals (ALNY) United States $37.826B 0.00
Argenex SE (ARGX) Netherlands $35.401B 96.63
BioNTech SE (BNTX) Germany $23.691B 0.00
BeiGene (ONC) Cayman Islands $23.652B 0.00
Biogen (BIIB) United States $18.813B 8.12
Royalty Pharma (RPRX) United States $18.380B 7.76
Genmab (GNMSF) Denmark $13.883B 14.20
Genmab (GMAB) Denmark $13.645B 15.31
Illumina (ILMN) United States $13.058B 24.77
Incyte (INCY) United States $12.650B 96.10
Insmed (INSM) United States $12.389B 0.00
Exelixis (EXEL) United States $11.751B 19.95
BioMarin Pharmaceutical (BMRN) United States $11.144B 18.10
Swedish Orphan Biovitrum (BIOVF) Sweden $10.783B 27.54
Exact Sciences (EXAS) United States $10.669B 0.00
Moderna (MRNA) United States $10.349B 0.00
QIAGEN (QGEN) Netherlands $9.747B 18.97
Ascendis Pharma (ASND) Denmark $9.589B 0.00
Roivant Sciences (ROIV) United Kingdom $7.678B 0.00
Bio-Techne Corp (TECH) United States $7.633B 28.47
Revolution Medicines (RVMD) United States $6.887B 0.00
Repligen (RGEN) United States $6.885B 77.07
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Jazz Pharmaceuticals (JAZZ) Ireland $6.748B 6.50
Halozyme Therapeutics (HALO) United States $6.706B 12.84
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.528B 0.00
Blueprint Medicines (BPMC) United States $6.462B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $6.437B 0.00
Telix Pharmaceuticals (TLX) Australia $5.691B 0.00
TG Therapeutics (TGTX) United States $5.595B 146.83
Legend Biotech (LEGN) United States $5.285B 0.00
Nuvalent (NUVL) United States $5.190B 0.00
Axsome Therapeutics (AXSM) United States $5.120B 0.00
Alkermes (ALKS) Ireland $4.931B 13.23
Zealand Pharma (ZLDPF) Denmark $4.923B 0.00
Guardant Health (GH) United States $4.853B 0.00
ADMA Biologics Inc (ADMA) United States $4.748B 35.52
Vaxcyte (PCVX) United States $4.093B 0.00
PTC Therapeutics (PTCT) United States $3.793B 6.60
Sarepta Therapeutics (SRPT) United States $3.769B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.765B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.714B 32.63
Akero Therapeutics (AKRO) United States $3.667B 0.00
Avidity Biosciences (RNA) United States $3.658B 0.00
Krystal Biotech (KRYS) United States $3.654B 28.16
Cytokinetics (CYTK) United States $3.646B 0.00
Merus (MRUS) Netherlands $3.516B 0.00
SpringWorks Therapeutics (SWTX) United States $3.501B 0.00
Zai Lab (ZLAB) China $3.422B 0.00
Alvotech (ALVO) Luxembourg $3.416B 19.53
Arcellx (ACLX) United States $3.414B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.317B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.245B 0.00
Viking Therapeutics (VKTX) United States $3.053B 0.00
Metsera (MTSR) United States $2.924B 0.00
Scholar Rock Holding (SRRK) United States $2.893B 0.00
Protagonist Therapeutics (PTGX) United States $2.878B 61.91
MoonLake Immunotherapeutics (MLTX) Switzerland $2.470B 0.00
Immunovant (IMVT) United States $2.427B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.338B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.261B 0.00
Ascentage Pharma Group - (AAPG) China $2.249B 0.00
ImmunityBio (IBRX) United States $2.233B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.173B 0.00
NovoCure (NVCR) Jersey $2.138B 0.00
Apellis Pharmaceuticals (APLS) United States $2.123B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.123B 0.00
Vericel (VCEL) United States $2.118B 1402.33
Bavarian Nordic (BVNRY) Denmark $2.058B 10.87
Belite Bio (BLTE) United States $1.962B 0.00
Ligand Pharmaceuticals (LGND) United States $1.961B 0.00
CG Oncology (CGON) United States $1.945B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.940B 12.90
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.933B 0.00
Amicus Therapeutics (FOLD) United States $1.921B 208.00
Denali Therapeutics (DNLI) United States $1.919B 0.00
Certara (CERT) United States $1.874B 35.00
Kymera Therapeutics (KYMR) United States $1.832B 0.00
Twist Bioscience (TWST) United States $1.762B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.760B 0.00
Agios Pharmaceuticals (AGIO) United States $1.749B 0.00
Beam Therapeutics (BEAM) United States $1.712B 0.00
IDEAYA Biosciences (IDYA) United States $1.701B 0.00
Apogee Therapeutics (APGE) United States $1.698B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.686B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.609B 0.00
Disc Medicine (IRON) United States $1.589B 0.00
Biohaven (BHVN) United States $1.566B 0.00
GRAIL (GRAL) United States $1.523B 0.00
Edgewise Therapeutics (EWTX) United States $1.507B 0.00
Janux Therapeutics (JANX) United States $1.434B 0.00
Mesoblast (MESO) Australia $1.402B 0.00
Adaptive Biotechnologies (ADPT) United States $1.389B 0.00
BGM Group (BGM) China $1.387B 0.00
Structure Therapeutics (GPCR) United States $1.368B 0.00
Travere Therapeutics (TVTX) United States $1.362B 0.00
89BIO (ETNB) United States $1.337B 0.00
Liquidia Technologies (LQDA) United States $1.334B 0.00
Celldex Therapeutics (CLDX) United States $1.313B 0.00
MannKind (MNKD) United States $1.278B 26.28
ANI Pharmaceuticals (ANIP) United States $1.263B 13.02
Vera Therapeutics (VERA) United States $1.214B 0.00
Novavax (NVAX) United States $1.195B 2.78
Pacira BioSciences (PCRX) United States $1.195B 11.37
Dynavax Technologies (DVAX) United States $1.174B 69.86
Viridian Therapeutics (VRDN) United States $1.137B 0.00
Anbio Biotechnology (NNNN) Germany $1.102B 0.00
Mineralys Therapeutics (MLYS) United States $1.025B 0.00
MiMedx (MDXG) United States $1.000B 24.18
CureVac (CVAC) Germany $0.976B 4.73
Intellia Therapeutics (NTLA) United States $0.966B 0.00
NeoGenomics (NEO) United States $0.965B 0.00
Arcus Biosciences (RCUS) United States $0.956B 0.00
Gyre Therapeutics (GYRE) United States $0.954B 254.50
Geron (GERN) United States $0.949B 0.00
WAVE Life Sciences (WVE) Singapore $0.916B 0.00
Spyre Therapeutics (SYRE) United States $0.904B 0.00
Oculis Holding AG (OCS) Switzerland $0.868B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.854B 0.00
CorMedix Inc (CRMD) United States $0.850B 56.96
UniQure (QURE) Netherlands $0.849B 0.00
Niagen Bioscience (NAGE) United States $0.835B 117.78
Pharvaris (PHVS) Netherlands $0.828B 0.00
LENZ Therapeutics (LENZ) United States $0.828B 0.00
Zymeworks (ZYME) United States $0.781B 0.00
Nuvation Bio (NUVB) United States $0.762B 0.00
Immunome (IMNM) United States $0.748B 0.00
Nurix Therapeutics (NRIX) United States $0.745B 0.00
Praxis Precision Medicines (PRAX) United States $0.735B 0.00
Pharming Group (PHAR) Netherlands $0.735B 0.00
ArriVent BioPharma (AVBP) United States $0.706B 0.00
Pharming Group (PHGUF) Netherlands $0.671B 0.00
Arbutus Biopharma (ABUS) United States $0.661B 0.00
Replimune (REPL) United States $0.649B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Vir Biotechnology (VIR) United States $0.644B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.639B 0.00
Anavex Life Sciences (AVXL) United States $0.629B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.626B 0.00
Trevi Therapeutics (TRVI) United States $0.615B 0.00
GH Research (GHRS) Ireland $0.609B 0.00
Immatics (IMTX) Germany $0.599B 0.00
AnaptysBio (ANAB) United States $0.591B 0.00
AbCellera Biologics (ABCL) Canada $0.591B 0.00
Keros Therapeutics (KROS) United States $0.583B 0.00
Iovance Biotherapeutics (IOVA) United States $0.578B 0.00
Sionna Therapeutics (SION) United States $0.577B 0.00
Dianthus Therapeutics (DNTH) United States $0.577B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.556B 0.00
Cogent Biosciences (COGT) United States $0.556B 0.00
Bicara Therapeutics (BCAX) United States $0.544B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.539B 0.00
Eton Pharmaceuticals (ETON) United States $0.537B 0.00
Opthea (OPT) Australia $0.525B 0.00
Upstream Bio (UPB) United States $0.517B 0.00
Stoke Therapeutics (STOK) United States $0.501B 11.62
Maze Therapeutics (MAZE) United States $0.491B 0.00
Arvinas (ARVN) United States $0.488B 0.00
Kura Oncology (KURA) United States $0.486B 0.00
Tyra Biosciences (TYRA) United States $0.468B 0.00
Verastem (VSTM) United States $0.468B 0.00
Cullinan Therapeutics (CGEM) United States $0.461B 0.00
Castle Biosciences (CSTL) United States $0.456B 30.98
REGENXBIO (RGNX) United States $0.455B 0.00
Sana Biotechnology (SANA) United States $0.451B 0.00
Zenas BioPharma (ZBIO) United States $0.442B 0.00
PureTech Health (PRTC) United States $0.432B 0.00
Septerna (SEPN) United States $0.430B 0.00
MBX Biosciences (MBX) United States $0.421B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.418B 0.00
Precigen (PGEN) United States $0.416B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.416B 0.00
Oric Pharmaceuticals (ORIC) United States $0.411B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.410B 0.00
MeiraGTx Holdings (MGTX) United States $0.409B 0.00
Sage Therapeutics (SAGE) United States $0.408B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.404B 0.00
Tectonic Therapeutic (TECX) United States $0.402B 0.00
Kamada (KMDA) Israel $0.399B 23.97
Celcuity (CELC) United States $0.399B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.397B 0.00
Northwest Biotherapeutics (NWBO) United States $0.389B 0.00
Humacyte (HUMA) United States $0.385B 0.00
Myriad Genetics (MYGN) United States $0.383B 0.00
Fortrea Holdings (FTRE) United States $0.376B 10.38
Vigil Neuroscience (VIGL) United States $0.368B 0.00
Benitec Biopharma (BNTC) United States $0.367B 0.00
Rapport Therapeutics (RAPP) United States $0.366B 0.00
Checkpoint Therapeutics (CKPT) United States $0.365B 0.00
Abivax SA (ABVX) France $0.361B 0.00
Olema Pharmaceuticals (OLMA) United States $0.352B 0.00
Absci (ABSI) United States $0.347B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.347B 0.00
ATyr Pharma (ATYR) United States $0.344B 0.00
Emergent Biosolutions (EBS) United States $0.343B 0.00
Fulcrum Therapeutics (FULC) United States $0.343B 0.00
Rezolute (RZLT) United States $0.328B 0.00
ITeos Therapeutics (ITOS) United States $0.326B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.326B 0.00
Cytek Biosciences (CTKB) United States $0.326B 0.00
Inventiva S.A (IVA) France $0.321B 0.00
Alpha Teknova (TKNO) United States $0.314B 0.00
Abeona Therapeutics (ABEO) United States $0.313B 0.00
Tvardi Therapeutics (TVRD) United States $0.313B 0.00
Erasca (ERAS) United States $0.306B 0.00
Cidara Therapeutics (CDTX) United States $0.301B 0.00
Aura Biosciences (AURA) United States $0.301B 0.00
XOMA Royalty (XOMA) United States $0.298B 0.00
Entrada Therapeutics (TRDA) United States $0.292B 9.51
Compass Therapeutics (CMPX) United States $0.292B 0.00
Prima BioMed (IMMP) Australia $0.291B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.288B 0.00
Candel Therapeutics (CADL) United States $0.281B 0.00
Ocugen (OCGN) United States $0.280B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Terns Pharmaceuticals (TERN) United States $0.263B 0.00
Lifecore Biomedical (LFCR) United States $0.259B 0.00
Inozyme Pharma (INZY) United States $0.255B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.255B 0.00
Gossamer Bio (GOSS) United States $0.255B 0.00
DBV Technologies S.A (DBVT) France $0.254B 0.00
Palvella Therapeutics (PVLA) United States $0.254B 0.00
MaxCyte (MXCT) United States $0.253B 0.00
Atea Pharmaceuticals (AVIR) United States $0.252B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.250B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.249B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.249B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.248B 0.00
Prothena (PRTA) Ireland $0.247B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.245B 49.88
Neurogene (NGNE) United States $0.244B 0.00
Semper Paratus Acquisition (TVGN) United States $0.237B 0.00
Allogene Therapeutics (ALLO) United States $0.236B 0.00
Solid Biosciences (SLDB) United States $0.236B 0.00
Amarin (AMRN) Ireland $0.235B 0.00
Third Harmonic Bio (THRD) United States $0.234B 0.00
Astria Therapeutics (ATXS) United States $0.231B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
Cartesian Therapeutics (RNAC) United States $0.228B 0.00
Foghorn Therapeutics (FHTX) United States $0.226B 0.00
Adherex Technologies (FENC) United States $0.225B 0.00
Tango Therapeutics (TNGX) United States $0.222B 0.00
Design Therapeutics (DSGN) United States $0.220B 0.00
Annexon (ANNX) United States $0.216B 0.00
Monopar Therapeutics (MNPR) United States $0.216B 0.00
GENFIT S.A (GNFT) France $0.214B 0.00
Adocia (ADOCY) France $0.213B 0.00
Aardvark Therapeutics (AARD) United States $0.213B 0.00
Codexis (CDXS) United States $0.211B 0.00
Alumis (ALMS) United States $0.210B 0.00
Cardiff Oncology (CRDF) United States $0.206B 0.00
EnGene Holdings (ENGN) Canada $0.204B 0.00
Actuate Therapeutics (ACTU) United States $0.202B 0.00
Nuvectis Pharma (NVCT) United States $0.202B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.200B 0.00
Innate Pharma S.A (IPHA) France $0.199B 0.00
Bright Minds Biosciences (DRUG) United States $0.193B 0.00
Galena Biopharma (SLS) United States $0.193B 0.00
BioStem Technologies (BSEM) $0.191B 7.79
CARGO Therapeutics (CRGX) United States $0.191B 0.00
Inhibrx Biosciences (INBX) United States $0.190B 0.11
Kodiak Sciences (KOD) United States $0.189B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.189B 0.00
ScPharmaceuticals (SCPH) United States $0.187B 0.00
Urogen Pharma (URGN) United States $0.181B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.179B 0.00
DiaMedica Therapeutics (DMAC) United States $0.178B 0.00
INmune Bio (INMB) United States $0.176B 0.00
CytomX Therapeutics (CTMX) United States $0.171B 4.43
Puma Biotechnology (PBYI) United States $0.171B 4.47
AC Immune (ACIU) Switzerland $0.170B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.167B 0.00
Prime Medicine (PRME) United States $0.167B 0.00
Molecular Partners AG (MOLN) Switzerland $0.164B 0.00
Anika Therapeutics (ANIK) United States $0.160B 0.00
Instil Bio (TIL) United States $0.159B 0.00
Voyager Therapeutics (VYGR) United States $0.156B 0.00
BioAge Labs (BIOA) United States $0.142B 0.00
Alpha Cognition (ACOG) Canada $0.141B 0.00
Fate Therapeutics (FATE) United States $0.140B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.138B 0.00
Editas Medicine (EDIT) United States $0.138B 0.00
Greenwich LifeSciences (GLSI) United States $0.133B 0.00
Rapt Therapeutics (RAPT) United States $0.129B 0.00
TuHURA Biosciences (HURA) United States $0.128B 0.00
Compugen (CGEN) Israel $0.128B 0.00
Alector (ALEC) United States $0.126B 0.00
Ventyx Biosciences (VTYX) United States $0.125B 0.00
Nkarta (NKTX) United States $0.123B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.122B 0.00
InflaRx (IFRX) Germany $0.122B 0.00
Theratechnologies (THTX) Canada $0.120B 0.00
EXoZymes (EXOZ) United States $0.117B 0.00
Black Diamond Therapeutics (BDTX) United States $0.117B 34.17
Seer (SEER) United States $0.115B 0.00
Neumora Therapeutics (NMRA) United States $0.113B 0.00
Kyverna Therapeutics (KYTX) United States $0.112B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.108B 0.00
Invivyd (IVVD) United States $0.108B 0.00
Sangamo Therapeutics (SGMO) United States $0.106B 0.00
Sagimet Biosciences (SGMT) United States $0.103B 0.00
BioHarvest Sciences (BHST) Canada $0.103B 0.00
Caribou Biosciences (CRBU) United States $0.101B 0.00
Elicio Therapeutics (ELTX) United States $0.101B 0.00
Nautilus Biotechnology (NAUT) United States $0.098B 0.00
Agenus (AGEN) United States $0.097B 0.00
Genelux (GNLX) United States $0.096B 0.00
Coya Therapeutics (COYA) United States $0.095B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.095B 0.00
HilleVax (HLVX) United States $0.093B 0.00
C4 Therapeutics (CCCC) United States $0.092B 0.00
Contineum Therapeutics (CTNM) United States $0.091B 0.00
Coherus BioSciences (CHRS) United States $0.090B 0.00
XBiotech (XBIT) United States $0.090B 0.00
Adagene (ADAG) China $0.090B 0.00
Cabaletta Bio (CABA) United States $0.088B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.086B 0.00
Senti Biosciences (SNTI) United States $0.086B 0.00
Immunic (IMUX) United States $0.085B 0.00
I-Mab (IMAB) United States $0.085B 0.00
Whitehawk Therapeutics (WHWK) United States $0.085B 0.00
Entera Bio (ENTX) Israel $0.085B 0.00
23andMe Holding (MEHCQ) United States $0.083B 0.00
Medicus Pharma (MDCX) United States $0.083B 0.00
Cellectis S.A (CLLS) France $0.081B 0.00
TScan Therapeutics (TCRX) United States $0.081B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.080B 0.00
Genenta Science S.p.A (GNTA) Italy $0.080B 0.00
Sutro Biopharma (STRO) United States $0.080B 0.00
Climb Bio (CLYM) United States $0.079B 0.00
Pliant Therapeutics (PLRX) United States $0.079B 0.00
Alto Neuroscience (ANRO) United States $0.078B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.076B 0.00
Forte Biosciences (FBRX) United States $0.076B 0.00
IO Biotech (IOBT) Denmark $0.075B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.074B 0.00
Tenaya Therapeutics (TNYA) United States $0.074B 0.00
Inovio Pharmaceuticals (INO) United States $0.073B 0.00
IGM Biosciences (IGMS) United States $0.073B 0.00
Jasper Therapeutics (JSPR) United States $0.072B 0.00
BeyondSpring (BYSI) United States $0.071B 0.00
Adlai Nortye (ANL) Cayman Islands $0.071B 0.00
Elutia (ELUT) United States $0.071B 0.00
MediciNova (MNOV) United States $0.070B 0.00
VistaGen Therapeutics (VTGN) United States $0.070B 0.00
CervoMed (CRVO) United States $0.069B 0.00
ZIVO Bioscience (ZIVO) United States $0.069B 0.00
Zura Bio (ZURA) United States $0.068B 0.00
Skye Bioscience (SKYE) United States $0.068B 0.00
PDS Biotechnology (PDSB) United States $0.065B 0.00
Clearside Biomedical (CLSD) United States $0.064B 0.00
Citius Oncology (CTOR) United States $0.064B 0.00
Akoya Biosciences (AKYA) United States $0.063B 0.00
Exicure (XCUR) United States $0.063B 0.00
Seres Therapeutics (MCRB) United States $0.063B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.062B 0.00
Opus Genetics (IRD) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
OKYO Pharma (OKYO) $0.059B 0.00
Immuneering (IMRX) United States $0.059B 0.00
TELA Bio (TELA) United States $0.059B 0.00
Repare Therapeutics (RPTX) Canada $0.058B 0.00
Adicet Bio (ACET) United States $0.058B 0.00
Celularity (CELU) United States $0.057B 0.00
Ikena Oncology (IKNA) United States $0.057B 0.00
Renovaro (RENB) United States $0.055B 0.00
Shattuck Labs (STTK) United States $0.055B 0.00
Immix Biopharma (IMMX) United States $0.055B 0.00
Kalaris Therapeutics (KLRS) United States $0.054B 0.00
Applied Therapeutics (APLT) United States $0.054B 0.00
Precision BioSciences (DTIL) United States $0.054B 0.00
Fortress Biotech (FBIO) United States $0.054B 0.00
Oncobiologics (OTLK) United States $0.054B 0.00
Werewolf Therapeutics (HOWL) United States $0.053B 0.00
Biomea Fusion (BMEA) United States $0.053B 0.00
VTv Therapeutics (VTVT) United States $0.051B 0.00
Cue Biopharma (CUE) United States $0.050B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
PepGen (PEPG) United States $0.048B 0.00
Artiva Biotherapeutics (ARTV) United States $0.048B 0.00
Adverum Biotechnologies (ADVM) United States $0.047B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.046B 0.00
Quince Therapeutics (QNCX) United States $0.046B 0.00
Xilio Therapeutics (XLO) United States $0.046B 0.00
RenovoRx (RNXT) United States $0.045B 0.00
Mersana Therapeutics (MRSN) United States $0.045B 0.00
Atara Biotherapeutics (ATRA) United States $0.045B 0.00
Rein Therapeutics (RNTX) United States $0.044B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.042B 0.00
Kronos Bio (KRON) United States $0.042B 0.00
Connect Biopharma Holdings (CNTB) United States $0.042B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.041B 0.00
CAMP4 Therapeutics (CAMP) United States $0.040B 0.00
Imunon (IMNN) United States $0.040B 0.00
Annovis Bio (ANVS) United States $0.040B 0.00
Spero Therapeutics (SPRO) United States $0.038B 0.00
Alterity Therapeutics - (ATHE) Australia $0.038B 0.00
Radiopharm Theranostics - (RADX) Australia $0.036B 0.00
Estrella Immunopharma (ESLA) United States $0.036B 0.00
Rani Therapeutics Holdings (RANI) United States $0.036B 0.00
Pluri (PLUR) Israel $0.036B 0.00
AN2 Therapeutics (ANTX) United States $0.036B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
Aligos Therapeutics (ALGS) United States $0.034B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
Scilex Holding (SCLX) United States $0.034B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.033B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.032B 0.00
Quantum Biopharma (QNTM) Canada $0.031B 0.00
Lantern Pharma (LTRN) United States $0.031B 0.00
FibroBiologics (FBLG) United States $0.031B 0.00
OnKure Therapeutics (OKUR) United States $0.031B 0.00
Grace Therapeutics (GRCE) Canada $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Boundless Bio (BOLD) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Femasys (FEMY) United States $0.028B 0.00
Dyadic (DYAI) United States $0.028B 0.00
Kezar Life Sciences (KZR) United States $0.028B 0.00
Cadrenal Therapeutics (CVKD) United States $0.028B 0.00
KALA BIO (KALA) United States $0.026B 0.00
Advanced Biomed (ADVB) United States $0.026B 0.00
Tenax Therapeutics (TENX) United States $0.025B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.025B 0.00
Generation Bio (GBIO) United States $0.025B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
CalciMedica (CALC) United States $0.025B 0.00
ALX Oncology Holdings (ALXO) United States $0.024B 0.00
Clene (CLNN) United States $0.024B 0.00
ABVC BioPharma (ABVC) United States $0.023B 0.00
BioAtla (BCAB) United States $0.022B 0.00
Passage Bio (PASG) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.022B 0.00
Vor Biopharma (VOR) $0.022B 0.00
Curis (CRIS) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.021B 0.00
Ovid Therapeutics (OVID) United States $0.021B 0.00
Q32 Bio (QTTB) United States $0.020B 0.00
Chemomab Therapeutics (CMMB) Israel $0.020B 0.00
Longeveron (LGVN) United States $0.020B 0.00
X4 Pharmaceuticals (XFOR) United States $0.020B 0.00
HOOKIPA Pharma (HOOK) United States $0.019B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
Elevation Oncology (ELEV) United States $0.018B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Gelteq (GELS) Australia $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
GeoVax Labs (GOVX) United States $0.016B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Cognition Therapeutics (CGTX) United States $0.016B 0.00
Leap Therapeutics (LPTX) United States $0.016B 0.00
Cingulate (CING) United States $0.016B 0.00
MetaVia (MTVA) United States $0.015B 0.00
Allarity Therapeutics (ALLR) United States $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
NextCure (NXTC) United States $0.014B 0.00
Synlogic (SYBX) United States $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
Rallybio (RLYB) United States $0.013B 0.00
IN8bio (INAB) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.013B 0.00
UNITY Biotechnology (UBX) United States $0.013B 0.00
Bionano Genomics (BNGO) United States $0.013B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Moleculin Biotech (MBRX) United States $0.013B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
Aytu BioPharma (AYTU) United States $0.012B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.012B 0.00
BRIACELL THERAP (BCTX) Canada $0.012B 0.00
HCW Biologics (HCWB) United States $0.012B 0.00
Hoth Therapeutics (HOTH) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Athira Pharma (ATHA) United States $0.011B 0.00
Dogwood Therapeutics (DWTX) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
LakeShore Biopharma (LSB) China $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
BioXcel Therapeutics (BTAI) United States $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Sensei Biotherapeutics (SNSE) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Intensity Therapeutics (INTS) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Eyenovia (EYEN) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Silo Pharma (SILO) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Polyrizon (PLRZ) Israel $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00